logo

UK News

Share

pharma-daily-042618.jpg EyePoint Pharmaceuticals gained 19.10% on Wednesday. The Company's NDA for YUTIQ micro-insert, proposed for treatment of non-infectious posterior segment uveitis, is under FDA review - with a decision expected on November 5, 2018.

shareslides-042318.jpg European stocks were broadly lower on Wednesday after Wall Street stocks sold off overnight on concerns over rising bond yields amid expectations of more Fed rate hikes this year. Corporate earnings also proved to be a mixed bag, weighing on investor sentiment. The pan-European Stoxx Europe 600 index...

sharessubdued-042318.jpg European stocks look set to open a tad lower on Wednesday as investors continued to fret over rising bond yields. The yield on 10-year U.S. Treasury note hit the key psychological level of 3 percent Tuesday for the first time since January 2014 due to fears of rising inflation and expectations the...

pharma-daily-041918.jpg The following are some of today's top gainers in the pharma/biotech sector.

sharesteady-042418.jpg European stocks were mostly higher on Tuesday as oil extended gains amid Middle East tensions and the dollar held steady near its highest level since January on expectations for a faster pace of interest-rate hikes. Amid another batch of mixed earnings updates, investors awaited the European Central...

pharma-042318.jpg Today's Daily Dose brings you news about Prothena pulling the plug on its AL amyloidosis drug candidate NEOD001; FDA panel thumbs up for lower dose of Baricitinib; imposition of FDA's partial hold on Epizyme's Tazemetostat program and FDA striking down Pfizer's Herceptin biosimilar.

sharesfirm-042418.jpg European stocks may open higher on Tuesday as Brent crude oil prices extended gains for a sixth day and a surge in U.S. bond yields pushed the value of the dollar higher against other major currencies. Oil prices hit their highest level since late 2014 on expectations of renewed U.S. sanctions against...

pharma-gainers-042318.jpg The following are some of today's top gainers in the pharma/biotech sector.

sharessubdued-042318.jpg European stocks were flat to slightly lower on Monday as earnings results from UBS disappointed investors and a rise in U.S. Treasury yields tempered optimism over easing geopolitical risks. The pan-European Stoxx Europe 600 index was down 0.12 percent at 381.38 in late opening deals after finishing...

stockhigher-042318.jpg European stocks may open a tad higher on Monday as the dollar held near a two-week high against a basket of major currencies, boosted by rising U.S. bond yields amid bets that the Federal Reserve will keep raising rates to prevent the world's largest economy from overheating. Asian stock markets are...

pharma-daily-041918.jpg Today's Daily Dose brings you news about Fresenius Kabi walking out of the Akorn deal; settlement of the long-running trade secret misappropriation suit between Alnylam) and Dicerna, and Abeona's gene therapy program ABO-202 for the treatment of Batten Disease securing Orphan Drug Designation in the European Union.

Follow RTT